Skip to main content

How Omada will Support Members Taking GLP-1s | Video Blog Part 7

While Omada is not directly prescribing GLP-1 medications like Ozempic, Mounjaro, and Weogvy, members who choose any “next level” obesity care will still receive a unique layer of support. 

From maintaining our high standard of science-backed, clinically-proven behavior change programs, we'll continue doing what we've done all along - meet our members where they are with the right information at the right time.

In the seventh and final part of Omada’s video blog series, Chief Medical Officer Carolyn Bradner Jasik, MD overviews how Omada will support members’ choices for managing their health through data-empowered, human-led coaching.